More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases

New York Stock Exchange/Archipelago
Notable
The Firm acted as Co-Lead Counsel for a class of seatholders seeking to enjoin the merger between the New York Stock Exchange and Archipelago Holdings, Inc. Lowey’s representation achieved revised merger terms, providing the seatholders with more than $250 million in additional consideration.

WorldCom
Notable
Lowey Dannenberg’s innovative strategy and aggressive prosecution produced an extraordinary recovery for the New York City Pension Funds in the In re WorldCom, Inc. Securities Litigation, substantially superior to that of any other WorldCom investor in either class or opt-out litigation.

Philip Services
Notable
After seven years of hard-fought litigation in the District Court and the Second Circuit Court of Appeals, Lowey Dannenberg achieved a $79 million settlement on behalf of United States investors of Philip Services Corp., a bankrupt Canadian resource recovery company.
News
Lowey Dannenberg Wins Class Certification in Ranbaxy Generic-Delay Case
On May 14, 2021, Judge Nathaniel M. Gorton of the U.S. District Court for the District of Massachusetts granted the End-Payor Plaintiffs’ (“EPPs’”) class certification motion. The EPPs are third party payors paying some or all of the purchase price for prescription…
Blog
Pharma Industry Takes Advantage of COVID Epidemic to Mislead Investors
Recently, several major players in the pharmaceutical industry have faced severe shareholder scrutiny for misleading the public regarding their roles in the production of COVID-19 vaccines. The company to most recently fall in the limelight is Emergent Biosolutions (“Emergent”). Emergent had…





